Royalty Floor. Notwithstanding anything to the contrary in the foregoing, in no event shall the reductions from Section 6.3(b) and Section 6.4, in the aggregate, reduce the royalties payable to MacroGenics for any Calendar Quarter by more than [****] percent ([****]%) of the payments that would otherwise be due for such Product pursuant to Section 6.3(a).
Appears in 4 contracts
Sources: License Agreement, License Agreement (Provention Bio, Inc.), License Agreement (Provention Bio, Inc.)
Royalty Floor. Notwithstanding anything to the contrary in the foregoing, in In no event shall the reductions from Section 6.3(b) and Section 6.4, in the aggregate, reduce will the royalties that would otherwise be payable to MacroGenics for any Calendar Quarter under Section 7.5.1, as reduced by this Section 7.5.3, be reduced by more than [****] percent (in any given Calendar Quarter as a result of any such reduction [****]%) of the payments that would otherwise be due for such Product pursuant to Section 6.3(a).
Appears in 2 contracts
Sources: Strategic Collaboration, Option and License Agreement (Odyssey Therapeutics, Inc.), Strategic Collaboration, Option and License Agreement (Odyssey Therapeutics, Inc.)